Key result
Struma lymphomatosa (Hashimoto) is characterized by a degenerative change in the thyroid gland with diffuse lymphoid infiltration between follicles and frequent formation of secondary nodules.
Reviews the clinical features and treatment of struma lymphomatosa (Hashimoto's thyroiditis).
Answers are grounded in this paper and cite their sources.
Distinguishes struma lymphomatosa from Riedel's struma in rare goiters; leaves open validation in larger cohorts before changing diagnostic practice.
Struma lymphomatosa (Hashimoto) is a rare type of abnormality of the thyroid gland, first described by Hashimoto in 1912.1Because of the infrequency of its occurrence, this type of goiter has been discussed almost exclusively by pathologists who, following Hashimoto's work, occasionally have noted in certain cases the curious histology which he described. By clinicians this lymphoid infiltration of the thyroid is generally considered as a type of chronic thyroiditis, usually Riedel's struma, which it closely resembles in many respects.2Since, however, pathologists3occasionally report this rare condition, it is of importance that the clinical features of struma lymphomatosa be reviewed and the results of treatment noted. The fundamental picture in struma lymphomatosa is that of a degenerative change in the thyroid gland, unaccompanied by evidence of acute inflammatory process. Microscopically one sees a diffuse lymphoid infiltration between the follicles, with the frequent formation of secondary nodules.
No takes yet. Share an insight, caveat, or question.
Howard M. Clute (1935) conducted a review in Struma lymphomatosa (Hashimoto). Struma lymphomatosa (Hashimoto) is characterized by a degenerative change in the thyroid gland with diffuse lymphoid infiltration between follicles and frequent formation of secondary nodules.
Synapse has enriched 10 related papers. Consider them for comparative context: